Our tentative conclusion is that ANXA1 and miR-196 changes are more closely related to the pathogenic features rather than the etiology of HNSCC and that correction of their misregulation could ameliorate conditions through cancer stem cell differentiation, its associated markers and decreased metastatic potential. This evidence concerns the gene ANXA1 and head and neck squamous cell carcinoma.